Coronavirus: Russia says its second COVID-19 vaccine is 100 pct effective
Russia’s consumer health watchdog Rospotrebnadzor on Tuesday said Russia’s second vaccine against COVID-19 is 100 percent effective based on the results of clinical trials, the TASS news agency reported.
Visit our dedicated coronavirus site here for all the latest updates.
Russia began mass trials of EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November.
Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92 percent effective at protecting people from COVID-19 according to interim results.
Read more:
Coronavirus: Russia says 1.5 mln people received Sputnik vaccine worldwide
Coronavirus: Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine
Pandemic over by May in countries that mass-inoculate with Sputnik V vaccine: RDIF
Also Read
-
Coronavirus: UK hospitals use blockchain to optimize tracking of COVID-19 vaccines
Two British hospitals are using blockchain technology to keep tabs on the storage and supply of temperature-sensitive COVID-19 vaccines, the companies ... Coronavirus -
Coronavirus: India vaccine developer warns some to avoid shot
India’s homegrown vaccine developer Bharat Biotech has warned people with weaker immunity and other medical conditions that include allergies, fever, ... Coronavirus -
‘Vaccines don’t save lives, vaccinations do,’ experts warn as COVID-19 deaths rise
While pharmaceutical companies have already managed to produce COVID-19 vaccines in record-breaking time, many people around the world remain vaccine ... Coronavirus
